News

Filter

Current filters:

Anti-viralsBiotechnology

1 to 9 of 228 results

Mylan to distribute Sovaldi and Harvoni in India

23-02-2015

US generics major Mylan said today that its Indian subsidiary has entered into an agreement with Gilead…

Anti-viralsBiotechnologyGileadHarvoniIndiaMarkets & MarketingMylanSovaldi

Gilead beats 4th-qtr 2014 expectations, as hepatitis C drug sales soar

Gilead beats 4th-qtr 2014 expectations, as hepatitis C drug sales soar

04-02-2015

US biotech firm Gilead Sciences posted fourth-quarter and full-year financial results after markets closed…

Anti-viralsBiotechnologyFinancialGilead SciencesHarvoniSovaldi

Chimerix to drop development of brincidofovir for Ebola

Chimerix to drop development of brincidofovir for Ebola

02-02-2015

US antiviral biopharma company Chimerix says that, after discussion with the US Food and Drug Administration,…

Anti-viralsBiotechnologybrincidofovirChimerixResearchTropical diseasesUSA

Valneva grants license to Immune Targeting Systems for the development of hepatitis B vaccine

Valneva grants license to Immune Targeting Systems for the development of hepatitis B vaccine

29-01-2015

France-based biotech firm Valneva and UK company Immune Targeting Systems (ITS) have signed an exclusive…

Anti-viralsBiotechnologyGlobalImmune Targeting SystemsLicensingValneva

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

26-01-2015

US biotech major Gilead Sciences has expanded its hepatitis C generic licensing agreements to include…

Anti-viralsBiotechnologyGenericsGilead SciencesIndiaLicensingSovaldiUSA

UK NICE recommends hepatitis C drugs Sovaldi and Olysio

UK NICE recommends hepatitis C drugs Sovaldi and Olysio

16-01-2015

In final draft guidance issued today, England health costs watchdog the National Institute for Health…

Anti-viralsBiotechnologyGilead SciencesJanssenJohnson & JohnsonOlysioPricingRegulationSovaldiUK

Gilead denied patent for hepatitis C drug Sovaldi in India

Gilead denied patent for hepatitis C drug Sovaldi in India

15-01-2015

The Indian Patent Controller yesterday rejected one of US biotech major Gilead Sciences’ key patent…

Anti-viralsBiotechnologyGileadIndiaLegalPatentssofosbuvirSovaldi

Tekmira to merge with OnCore, to create major hep B company

Tekmira to merge with OnCore, to create major hep B company

14-01-2015

Shares of Tekmira Pharmaceuticals leapt as much as 50% after it announced a merger with privately-held…

Anti-viralsBiotechnologyOnCore BioPharmaOnCore BioPharmaTekmira PharmaceuticalsUSA

1 to 9 of 228 results

COMPANY SPOTLIGHT

Menarini

Back to top